Blueprint Genetics partners with Face2Gene to demonstrate the new LABS application and discuss “New Standards in Genetic Interpretation with Next Generation Phenotyping.” Dr. Peter Krawitz of Chartié Berlin will also discuss the multi-center PEDIA study, addressing a probabilistic interpretation of big data consisting of phenotype and genotype information.
This webinar hosted by Dr. Tero-Pekka Alastalo, Blueprint Genetics, will show you how to increase diagnostic yield of genetic tests through the new Face2Gene LABS application.
Dr. Tero-Pekka Alastalo, MD, PhD
Chief Medical Officer, Blueprint Genetics
Dr. med. Peter Krawitz, Dipl. Phys
Medical Genetics, Charité Berlin
Sarah Reilly, MS, CGC
Director, Customer Success, FDNA